Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Bektas, Nuran ^a   ten Haaf, Anette ^a   Veeck, Jürgen ^a   Wild, Peter Johannes ^b   Lüscher Firzlaff, Juliane ^a   Hartmann, Arndt ^c   Knüchel, Ruth ^a   Dahl, Edgar ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; PARAFFIN; PROGESTERONE RECEPTOR; RNA; TRANSCRIPTION FACTOR FOXM1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TISSUE MICROARRAY; UNIVARIATE ANALYSIS; CANCER STAGING; CASE CONTROL STUDY; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PAGET NIPPLE DISEASE; PREDICTION AND FORECASTING; PROTEIN MICROARRAY; PROTO ONCOGENE; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SAMPLING STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 40749137718     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-42     Document Type: Article

References (28)

1. Kaestner KH Knochel W Martinez DE Unified nomenclature for the winged helix/forkhead transcription factors Genes Dev 2000, 14(2):142-6. 10702024
2. Lehmann OJ Sowden JC Carlsson P Jordan T Bhattacharya SS Fox's in development and disease Trends Genet 2003, 19(6):339-44. 10.1016/ S0168-9525(03)00111-2 12801727
3. Korver W Roose J Clevers H The winged-helix transcription factor Trident is expressed in cycling cells Nucleic Acids Res 1997, 25(9):1715-9. 146663 9108152 10.1093/nar/25.9.1715
4. Yao KM Sha M Lu Z Wong GG Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain J Biol Chem 1997, 272(32):19827-36. 10.1074/jbc.272.32.19827 9242644
5. Korver W Schilham MW Moerer P van den Hoff MJ Dam K Lamers WH Medema RH Clevers H Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident Curr Bio 1998, 8(24):1327-30. 10.1016/S0960-9822(07)00563-5
6. Leung TW Lin SS Tsang AC Tong CS Ching JC Leung WY Gimlich R Wong GG Yao KM Over-expression of FOXM1 stimulates cyclin B1 expression FEBS Lett 2001, 507(1):59-66. 10.1016/S0014-5793(01)02915-5 11682060
7. Wonsey DR Follettie MT Loss of the Forhhead Transcription Factor FOXM1 Causes Centrosome Amplification and Mitotic Catastrophe Cancer Res 2005, 65(12):5181-5189. 10.1158/0008-5472.CAN-04-4059 15958562
8. Okabe H Satoh S Kato T Kitahara O Yanagawa R Yamaoka Y Tsunoda T Furukawa Y Nakamura Y Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression Cancer Res 2001, 61(5):2129-37. 11280777
9. Castedo M Perfettini JL Roumier T Andreau K Medema R Kroemer G Cell death by mitotic catastrophe: A molecular definition Oncogene 2004, 23(16):2825-37. 10.1038/sj.onc.1207528 15077146
10. Madureira PA Varshochi R Constantinidou D Francis RE Coombes RC Yao KM Lam EW The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells J Biol Chem 2006, 281(35):25167-76. 10.1074/jbc.M603906200 16809346
11. Khan SA Rogers MA Khurana KK Meguid MM Numann PJ Estrogen receptor expression in benign breast epithelium and breast cancer risk J Natl Cancer Inst 1998, 90(1):37-42. 10.1093/jnci/90.1.37 9428781
12. Ricketts D Turnbull L Ryall G Bakhshi R Rawson NS Gazet JC Nolan C Coombes RC Estrogen and progesterone receptors in the normal female breast Cancer Res 1991. 51(7):1817-22. 2004366
13. Moy B Goss PE Estrogen receptor pathway: Resistance to endocrine therapy and new therapeutic approaches Clin Cancer Res 2006, 12(16):4790-3. 10.1158/1078-0432.CCR-06-1535 16914563
14. Coombes RC Powles TJ Berger U Wilson P McClelland RA Gazet JC Trott PA Ford HT Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates Lancet 1987, 2(8561):701-3. 10.1016/S0140-6736(87)91071-3 2888939
15. Taylor RE Powles TJ Humphreys J Bettelheim R Dowsett M Casey AJ Neville AM Coombes RC Effects of endocrine therapy on steroid-receptor content of breast cancer Br J Cancer 1982, 45(1):80-5. 6277358
16. Dahl E Sadr-Nabavi A Klopocki E Betz B Grube S Kreutzfeld R Himmelfarb M Gelling S Klaman I Hinzmann B Kristiansen G Grützmann R Kuner R Petschke B Rhiem K Wiechen K Sers C Wiestler O Schneider A Höfler H Nährig J Dietel M Schäfer R Rosenthal A Schmutzler R Dürst M Meindl A Niederacher D Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer J Pathol 2005, 205(1):21-8. 10.1002/path.1687 15586368
17. Dahl E Kristiansen G Gottlob K Klaman I Ebner E Hinzmann B Hermann K Pilarsky C Durst M Klinkhammer-Schalke M Blaszyk H Knuechel R Hartmann A Rosenthal A Wild PJ Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer Clin Cancer Res 2006, 12(13):3950-60. 10.1158/1078-0432.CCR-05-2090 16818692
18. Gusarova GA Wang IC Major ML Kalinichenko VV Ackerson T Petrovic V Costa RH A cell-penetrating ARF peptide inhibitor of FOXM1 in mouse hepatocellular carcinoma treatment J Clin Invest 2007, 117(1):99-111. 1697798 17173139 10.1172/JCI27527
19. Radhakrishnan SK Bhat UG Hughes DE Wang IC Costa RH Gartel AL Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box m1 Cancer Res 2006, 66(19):9731-5. -10.1158/ 0008-5472.CAN-06-1576 17018632
20. Elston CW Ellis IO Pathological prognostic factors inbreast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 1991, 19(5):403-10. 10.1111/j.1365-2559.1991.tb00229.x 1757079
21. Zafrakas M Chorovicer M Klaman I Kristiansen G Wild PJ Heindrichs U Knüchel R Dahl E Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue Int J Cancer 2006, 118(6):1453-9. 10.1002/ijc.21517 16187283
22. Veeck J Niederacher D An H Klopocki E Wiesmann F Betz B Galm O Camara O Durst M Kristiansen G Huszka C Knuchel R Dahl E Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis Oncogene 2006, 25(24):3479-88. 10.1038/ sj.onc.1209386 16449975
23. Remmele W Stegner HE Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 1987, 8(3):138-40. 3303008
24. Gallagher SM Castorino JJ Wang D Philp NJ Monocarboxylate Transporter 4 Regulates Maturation and Trafficking of CD147 to the Plasma Membrane in the Metastatic Breast Cancer Cell Line MDA-MB-231 Cancer Res 2007, 67(9):4182-9. 10.1158/0008-5472.CAN-06-3184 17483329
25. Yang H Zhao R Yang HY Lee MH Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity Oncogene 2005, 24(11):1924-35. 10.1038/sj.onc.1208352 15688030
26. Stern DF Heffernan PA Weinberg RA p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity Mol Cell Biol 1986, 6(5):1729-40. 367701 2878363
27. Ross JS Fletcher JA Linette GP Stec J Clark E Ayers M Symmans WF Pusztai L Bloom KJ The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy Oncologist 2003, 8(4):307-25. 10.1634/ theoncologist.8-4-307 12897328
28. Nahta R Esteva FJ HER2 therapy. Molecular mechanisms of trastuzumab resistance Breast Cancer Res 2006, 8(6):215. 1797036 17096862 10.1186/ bcr1612